Nightingale

Nightingale, developed by Medical Marijuana Genetics, is a hybrid between Shiskaberry and their Candida with 10-20% CBD content. There are basically two phenotypes of Nightingale: one closer to Candida, more Sativa and with 1:1 THC:CBD ratio, and another one more Indica which, according to the studies conducted by MMG, can reach 1:20 THC:CBD ratio, up to 20% cannabidiol. The flowering period lasts around 8-9 weeks, while yields are between 300 and 500g/m2 of frosty buds. According to MMG, this strain is suitable to treat chronic pain, nausea, vomiting, insomnia and also multiple sclerosis. Medical Marijuana Genetics Nightingale info: Genetics: Shiskaberry x Candida Type: Feminized seeds Mostly Indica hybrid Indoor flowering: 8-99 weeks Yield: 300-500g/m2 THC content: from 0,68 to 9% CBD content: from 10,3% to 20,3% THC:CBD ratio: from 1:1 to 1:20